Detalhe da pesquisa
1.
Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study.
Clin Exp Med
; 23(8): 5113-5120, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37634231
2.
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers.
Angiogenesis
; 15(2): 275-86, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22382585
3.
A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients.
NPJ Breast Cancer
; 8(1): 33, 2022 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314692
4.
Discordant somatic and germline VEGF-A genotype in a cancer patient resistant to paclitaxel/bevacizumab with chemosensitive hepatic metastasis.
Pharmacogenomics
; 10(8): 1225-9, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19663667
5.
Metronomic cyclophosphamide in elderly patients with advanced, castration-resistant prostate cancer.
J Am Geriatr Soc
; 58(5): 986-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20722827